Depression therapy with injection drug users: Results of a pilot study

American Journal of Drug and Alcohol Abuse

Volumn 31, Issue 2, 2005, Pages 243-251

  Hawkins, Wesley E ^a   Latkin, Carl ^b   Green, Diane L ^a,c  

^a FLORIDA ATLANTIC UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c NONE   (United States)

Author keywords

Depression; Injection drug users

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; PILOT STUDY; PSYCHOTHERAPY; RISK REDUCTION; SYMPTOM; TREATMENT OUTCOME;

ADULT; COGNITIVE THERAPY; DEPRESSION; FEMALE; HIV INFECTIONS; HUMANS; MALE; PILOT PROJECTS; RISK REDUCTION BEHAVIOR; SUBSTANCE ABUSE, INTRAVENOUS; TREATMENT OUTCOME;

EID: 18544371187     PISSN: 00952990     EISSN: None     Source Type: Journal    
DOI: 10.1081/ADA-200047928     Document Type: Article

References (18)

1. Woody GE, McLellan T, O'Brien CP, Luborsky L. Addressing psychiatric comorbidity. NIDA Research Monograph Series 1991; 106:152-166.
2. Gonzales GM, Munoz RF, Perez-Arce P, Batki SL. Depression and HIV disease in injection drug users: a Spanish language feasibility study. Special Series: psychosocial treatment of the addictions. Psychol Addict Behav 1993; 7(3):149-154.
3. Kelly JA, Murphy DA, Bahr RG, Kalichman SC, Morgan MG, Stevenson Y, Koob JJ, Brasfield TL, Bernstein BM. Outcome of cognitive-behavioral and support group brief therapies for depressed HIV infected persons. Am J Psychiatry 1993; 150:1679-1686.
4. Orr S, Celentano D, Santelli J, Burwell L. Depressive symptoms and risk factors for HIV acquisition among black women attending urban health centers in Baltimore. AIDS Educ Prev 1994; 6(3):230-236.
5. Latkin C, Mandell W. depression as an antecedent to HIV risk behavior in injection drug users. Int J Addict 1992; 29:353-359.
6. Hawkins W, Latkin C, Hawkins M, Mandell W. Depressive symptoms and HIV risk behavior in inner-city users of drug injections. Psy Rep 1998; 82:137-138.
7. Radloff LS. The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977; 1:385-401.
8. Hawkins W, Latkin C, Hawkins M, Mandell W. Predictors of outcome in a social network HIV risk reduction intervention with injection drug users. Soc Work Res Abstr, (Submitted).
9. Mandell W, Latkin C. The SAFE HIV Risk Behavior Survey. Unpublished manuscript.
10. Vlahov D, Anthony JC, Munoz A, Margolick JB, Mandell W, Nelson KW, Polk BF. ALIVE study: a longitudinal study of HIV infection among intravenous drug issues. J Drug Issues 1991; 21:755-771.
11. Beck AT, Wright FD, Newman CF, Liese BS. Cognitive Therapy of Substance Abuse. New York: Guilford Press, 1993.
12. Crosbie J. Interrupted time series analysis with brief single-subject data. J Consult Clin Psychol 1993; 61(6):966-974.
13. Wallen MC, Weiner HD. Impediments to effective treatment of the dually diagnosed patient. J Psychoact Drugs 1989; 21(2):161-168.
14. Niaura RS, Rohsenow DJ, Binkoff JA, Monti PM, Pedraza M, Abrams DB. Relevance to cue activity to understanding alcohol and smoking relapse. J Abnorm Psychology 1988; 97(2):133-152.
15. Beck AT, Rush AJ, Shaw BF, Emery G. Cognative Therapy of Depression. New York: Guilford Press, 1979.
16. Beck AT. Depression: Clinical, Experimental, and Theoretical Aspects. New York: Harper Row, 1967.
17. Lewinsohn PM, Lobitz WC, Wilson S. "Sensitivity" of depressed individuals to aversive stimuli. J Abnorm Psychology 1973; 81:259-263.
18. Blechman EA, Wills TA. Process measures in interventions for drug abusing women: from coping to competence. In: Kilbey MM, Asghar K, eds. Methodological Issues in Research on Drug-Exposed Women and their Children. Rockville, MD: National Institute of Drug Abuse, 1992:314-343.